Sh Fosun Pharma reported CNY13.07B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Cspc Pharmaceutical CNY 6.09B 1.48B Dec/2025
Jiangsu Hengrui CNY 40.53B 428.6M Mar/2026
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Sh Pharmaceutical CNY 31.21B 5.52B Mar/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Wuxi Apptec CNY 35.73B 179.4M Jun/2026
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026